-->

CITIC Envirotech - CIMB Research 2016-07-27: Three-pronged approach working well

CITIC Envirotech - CIMB Research 2016-07-27: Three-pronged approach working well CITIC ENVIROTECH LTD U19.SI 

CITIC Envirotech - Three-pronged approach working well

  • CEL’s 1H16 core net profit was above our full-year estimate at 62% due to strong growth in all three segments: engineering, treatment and membrane sales.
  • Low net gearing of 25.4% and S$362m (US$267m) remaining proceeds from issuance of perpetual capital securities to support more aggressive growth.
  • Recent opening of membrane facility in Singapore and partnership could stimulate external membrane sales and act as a potential re-rating catalyst.
  • We cut our FY16-18 EPS estimates by 24-34% to account for preferred dividends.
  • Maintain Add with lower DCF-based target price of S$1.52 (7% WACC).



Exceptional 2Q16 earnings thanks to growth in all three segments

  • CEL reported 2Q16 revenue of S$140m (US$103m), up 67% yoy, thanks to stronger growth in all three segments: engineering revenue (+105% yoy), treatment income (+24% yoy) and membrane sales (+78% yoy). 
  • As a result, 1H16 core net profit came in above our FY16 forecast at 62%, partly helped by the absence of tax distortion in 1H15. 
  • 2Q16 gross margin was relatively stable at 34.9% (vs. 34.3% in 2Q15) despite greater proportion of construction at 56% of revenue in 2Q16 (2Q15: 46%).


Adjustment for preferred dividends

  • After factoring in dividends attributable to perpetual capital securities, CEL’s 1H16 core net profit was in line with our FY16 estimate at 52%. 
  • We adjust our EPS estimates for the dividends arising from recent issuance of perpetual capital securities (US$355m to date, 5.45%), which resulted in our FY16-18 EPS cuts of 24-34%.


Strong balance sheet with cash proceeds to pursue growth

  • Although net gearing crept up slightly from 20.2% at end-1Q16 to 25.4% at end-2Q16, CEL’s balance sheet is still one of the strongest among its peers, enabling it to undertake more wastewater treatment (WWT) projects and aggressively pursue larger- scale M&As. 
  • Approximately S$362m (US$267m) of proceeds from recent issuance of perpetual capital securities (total US$355m) remains unutilised.


Expanded production facility to facilitate higher membrane sales

  • CEL subsidiary Memstar recently opened a S$25m (US$18m) innovation centre and membrane production facility in Singapore. This 5,100 sqm new membrane production facility doubles the production capacity of its patented third generation Thermally Induced Phase Separation (3G-TIPS) membranes to 10m sqm p.a. 
  • Together with the partnership with Hydranautics on the design, fabrication and sales of containerised membrane systems, we believe this could boost external membrane sales.


Maintain Add with lower DCF-based target price of S$1.52

  • While we raise our assumptions for construction work and membrane sales in FY16, we fine-tune those beyond FY18 as we think they were too aggressive. Hence, our DCF- based target price drops slightly to S$1.52 (WACC: 7%). 
  • Maintain Add. 
  • Risks to our Add call are slower-than-expected project pipeline and uptake of membrane.




NGOH Yi Sin CIMB Securities | Roy CHEN CIMB Securities | http://research.itradecimb.com/ 2016-07-27
CIMB Securities SGX Stock Analyst Report ADD MAINTAIN ADD 1.52 Down 1.61


Advertisement



MOST TALKED ABOUT STOCKS / REITS OF THE WEEK



loading.......